nitrites has been researched along with Fatty Liver, Nonalcoholic in 8 studies
Nitrites: Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M=metal) are all insoluble, except the alkali nitrites. The organic nitrites may be isomeric, but not identical with the corresponding nitro compounds. (Grant & Hackh's Chemical Dictionary, 5th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dietary nitrite suppressed liver fibrosis in the rats by reducing oxidative stress, as measured using the protein levels of nicotinamide adenine dinucleotide phosphate oxidase components and inflammatory cell accumulation in the liver." | 1.72 | Beneficial Effects of Dietary Nitrite on a Model of Nonalcoholic Steatohepatitis Induced by High-Fat/High-Cholesterol Diets in SHRSP5/Dmcr Rats: A Preliminary Study. ( Kasono, K; Kitamori, K; Kobayashi, J; Kono, Y; Ohtake, K; Shiba, S; Sonoda, K, 2022) |
| "Thirty-four patients with NAFLD, and 19 healthy controls were included." | 1.42 | Serum levels of nitrate, nitrite and advanced oxidation protein products (AOPP) in patients with nonalcoholic fatty liver disease. ( Akbal, E; Cesur, S; Çiftci, A; Erden, G; Ergül, B; Koçak, E; Köklü, S; Özsoy, M; Öztürk, G; Yilmaz, B; Yüksel, O, 2015) |
| "Nonalcoholic fatty liver disease is a chronic metabolic disorder with significant impact on cardiovascular and liver mortality." | 1.38 | Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis. ( Bucchieri, F; Bugianesi, E; Galvano, F; Li Volti, G; Mangiameli, A; Marino Gammazza, A; Marino, A; Parola, M; Paternostro, C; Salamone, F; Tibullo, D, 2012) |
| "The role of adiponectin receptors in NAFLD progression remains still unclear." | 1.37 | Hepatic expression of adiponectin receptors increases with non-alcoholic fatty liver disease progression in morbid obesity in correlation with glutathione peroxidase 1. ( Alcázar, LM; Caballero, T; Carazo, A; Casado, J; Delgado, S; Gila, A; León, J; Martín, A; Muñoz, JA; Quiles, R; Ruiz-Extremera, A; Salmerón, J; Sanjuan, L, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sonoda, K | 1 |
| Kono, Y | 1 |
| Kitamori, K | 1 |
| Ohtake, K | 1 |
| Shiba, S | 1 |
| Kasono, K | 1 |
| Kobayashi, J | 1 |
| Abu-Halaka, D | 1 |
| Gover, O | 1 |
| Rauchbach, E | 1 |
| Zelber-Sagi, S | 1 |
| Schwartz, B | 1 |
| Tirosh, O | 1 |
| Cayuela, NC | 1 |
| Negreti, GP | 1 |
| Rasslan, R | 1 |
| Koike, MK | 1 |
| Montero, EFS | 1 |
| Jorgačević, B | 2 |
| Mladenović, D | 2 |
| Ninković, M | 2 |
| Prokić, V | 1 |
| Stanković, MN | 1 |
| Aleksić, V | 1 |
| Cerović, I | 1 |
| Vukićević, RJ | 1 |
| Vučević, D | 2 |
| Stanković, M | 1 |
| Radosavljević, T | 2 |
| Vesković, M | 1 |
| Dragutinović, V | 1 |
| Vatazević, A | 1 |
| Ješić Vukićević, R | 1 |
| Çiftci, A | 1 |
| Yilmaz, B | 1 |
| Köklü, S | 1 |
| Yüksel, O | 1 |
| Özsoy, M | 1 |
| Erden, G | 1 |
| Öztürk, G | 1 |
| Akbal, E | 1 |
| Ergül, B | 1 |
| Koçak, E | 1 |
| Cesur, S | 1 |
| Carazo, A | 1 |
| León, J | 1 |
| Casado, J | 1 |
| Gila, A | 1 |
| Delgado, S | 1 |
| Martín, A | 1 |
| Sanjuan, L | 1 |
| Caballero, T | 1 |
| Muñoz, JA | 1 |
| Quiles, R | 1 |
| Ruiz-Extremera, A | 1 |
| Alcázar, LM | 1 |
| Salmerón, J | 1 |
| Salamone, F | 1 |
| Galvano, F | 1 |
| Marino Gammazza, A | 1 |
| Marino, A | 1 |
| Paternostro, C | 1 |
| Tibullo, D | 1 |
| Bucchieri, F | 1 |
| Mangiameli, A | 1 |
| Parola, M | 1 |
| Bugianesi, E | 1 |
| Li Volti, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Dapagliflozin on Cardio-Metabolic Risk Factors in Patients With Type-2 Diabetes[NCT03377335] | Phase 4 | 186 participants (Anticipated) | Interventional | 2017-12-22 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 other studies available for nitrites and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Beneficial Effects of Dietary Nitrite on a Model of Nonalcoholic Steatohepatitis Induced by High-Fat/High-Cholesterol Diets in SHRSP5/Dmcr Rats: A Preliminary Study.
Topics: Animals; Captopril; Cholesterol; Diet, High-Fat; Disease Models, Animal; Liver; Liver Cirrhosis; Nit | 2022 |
Whole body metabolism is improved by hemin added to high fat diet while counteracted by nitrite: a mouse model of processed meat consumption.
Topics: Animals; Diet, High-Fat; Energy Metabolism; Hemin; Inflammation; Male; Meat Products; Mice; Mice, In | 2021 |
Oxidative stress on ischemia/reperfusion injury in mice with non-alcoholic hepatic steatosis or steatohepatitis.
Topics: Animals; Disease Models, Animal; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Nitrites; Non-a | 2018 |
Dynamics of oxidative/nitrosative stress in mice with methionine-choline-deficient diet-induced nonalcoholic fatty liver disease.
Topics: Animals; Antioxidants; C-Reactive Protein; Catalase; Choline Deficiency; Disease Models, Animal; Fer | 2014 |
Rimonabant Improves Oxidative/Nitrosative Stress in Mice with Nonalcoholic Fatty Liver Disease.
Topics: Animals; Cannabinoid Receptor Antagonists; Diet, High-Fat; Disease Models, Animal; Glutathione; Live | 2015 |
Serum levels of nitrate, nitrite and advanced oxidation protein products (AOPP) in patients with nonalcoholic fatty liver disease.
Topics: Adult; Advanced Oxidation Protein Products; Biomarkers; Case-Control Studies; Female; Humans; Male; | 2015 |
Hepatic expression of adiponectin receptors increases with non-alcoholic fatty liver disease progression in morbid obesity in correlation with glutathione peroxidase 1.
Topics: Adult; Biomarkers; Cohort Studies; Disease Progression; Fatty Liver; Female; Glutathione Peroxidase; | 2011 |
Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis.
Topics: Alanine Transaminase; Analysis of Variance; Animals; Antioxidants; Choline Deficiency; Cytokines; Di | 2012 |